Regulatory Updates
🇺🇸 FDA Page 21FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.
Showing 241–252 of 373 articles
FDA PreCheck Pilot Program Launches: A New Era for Clinical Trials
Experimental IgG4-RD Drug Submission to FDA After Successful Trial
Seven Biopharma Trends to Watch in 2026: Clinical Trials Insights
Leap Therapeutics Stock Edges Higher After Recent Data
Biopharma Dealmaking in 2025: Market Analysis
FDA Loosens Regulations on Digital Health Tools
Global Firms Pursue China Deals Amid Economic Uncertainty
US FDA Extends Decision Date for Camizestrant Filing
GSK and Alfasigma Licensing Agreement, Servier's $2.5B Acquisition
Eli Lilly Acquires 3 Vaccine Developers in $3.8B Deal
Top 10 Most Anticipated Drug Launches of 2026
FDA Guidelines Enhance Generic Bioequivalence in Oncology Drugs